Search - tctmd.com

Displaying 1 - 20 of 30

Sort: Relevancy | Date

Presentation TCT 2025

TCT 69: Optimal P2Y12 inhibitor strategy after acute coronary syndrome: a network meta-analysis of randomised controlled trials

Presenter: Yousif Ahmad

October 28, 2025

Presentation TCT 2025

TCT 772: Optimal Antithrombotic Therapy in Patients with Peripheral Artery Disease: A Systematic Review and Network Meta-analysis of Randomized Clinical Trials

Presenter: Yuriko Hiruma

October 26, 2025

Presentation TCT 2025

Revascularization vs. Optimal Medical Therapy of Chronic Total Occlusions for Symptom Relief and Quality of Life: From the EUROCTO and DECISION-CTO Randomized Trials

Presenter: Gerald S. Werner

October 25, 2025

Presentation NY Valves 2025

Defining an Optimal Result of Transcatheter Tricuspid Valve Intervention: Results From the Tri-QOL Study

Presenter: Suzanne V. Arnold

June 26, 2025

Presentation TCT 2024

TRISCEND II Trial: Transcatheter Valve Replacement vs. Optimal Medical Therapy for Severe Tricuspid Regurgitation

Presenter: Susheel Kodali

October 30, 2024

Presentation TCT 2024

TCT 390: Characteristics Associated With Optimal Stent Expansion in Patients With Calcified Lesions Receiving Rotational Atherectomy With or Without Cutting Balloon: A Secondary Analysis From the ROTA-CUT Randomized Trial

Presenter: Angelo Oliva

October 28, 2024

Presentation TCT 2024

TCT 362: Optimal Pre-Dilatation Treatment Before Implantation of a Magmaris Bioresorbable Scaffold in Coronary Artery Stenosis: The OPTIMIS Trial

Presenter: Kirstine Hansen

October 27, 2024

Presentation TCT 2023

TCT 515: Optimal Antiplatelet Strategy for Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. A trial-sequential, bivariate, influential, and network meta-analysis

Presenter: Harigopal Sandhyavenu

October 24, 2023

Presentation TCT 2023

TCT 417: Ten-Year Clinical Outcomes After Randomization to PCI of a Concurrent Chronic Total Coronary Occlusion or Optimal Medical Therapy Alone in Patients With STEMI: Extended Follow-Up of the EXPLORE Trial

Presenter: Anna van Veelen

October 24, 2023

Presentation TCT 2023

TCT 670: Sub-optimal OCT-guiding and Association with Two-year Clinical Outcomes - An OCTOBER Trial Substudy

Presenter: Omeed Neghabat

October 24, 2023

Presentation TCT 2023

Ten-Year Clinical Outcomes after PCI of a Concurrent Chronic Total Coronary Occlusion or Optimal Medical Therapy Alone in Patients with STEMI: Extended Follow-Up of the EXPLORE trial

Presenter: Anna van Veelen

October 23, 2023

Presentation TCT 2022

TCT 304: Non-Invasive Assessment of Microvascular Dysfunction After Optimal Coronary Artery Stent Deployment; Insight From Acetyl Salicylic Elimination Trial (ASET) Japan

Presenter: Shinichiro Masuda

September 19, 2022

Presentation TCT 2022

TCT 199: A Symptom-Stratified Analysis of the Objective Randomised Blinded Investigation With Optimal Medical Therapy of Angioplasty in Stable Angina Trial

Presenter: Rachel Pathimagaraj

September 18, 2022

Presentation TCT 2022

Endovascular Sequestration of High-Risk Carotid Lesions Using the MicroNET-Covered Embolic Prevention Stent in Consecutive Patients With Symptoms or Signs of Carotid Stenosis-Related Cerebral Injury: An Investigator-Initiated, Intravascular, Ultrasound…

Presenter: Piotr Musialek

September 17, 2022

Presentation TCT 2021

Heart Failure Interventions – Defining Optimal Medical Therapy in a Device Trial, From FDA Perspective

Presenter: Meir Shinnar

November 05, 2021

Presentation TCT 2021

Heart Failure Interventions – Defining Optimal Medical Therapy in a Device Trial, From Academic Perspective

Presenter: William Abraham

November 05, 2021

Presentation TCT 2018

COMPASS Trial Revisited: Weighing Rivaroxaban Secondary Prevention vs DAPT After PCI

Presenter: Deepak L. Bhatt, Tullio Palmerini, Michael Maeng

September 23, 2018

Presentation TCT 2018

TCT-1: Optimal Duration of Dual Antiplatelet Therapy After Left Main Coronary Stenting With Everolimus-Eluting Stents: Analysis From the EXCEL Trial

Presenter: Steven R. Bailey, Patrick W. Serruys, Sorin J. Brener

September 22, 2018

Presentation TCTAP 2018

OPTIMA Trial: P2Y12 Dose Adjustment for East-Asian ACS Patients

Presenter: Duk-Woo Park

April 28, 2018

Presentation TCT 2017

Debate: With Improved Technology and Optimal Technique ABSORB Will Become a Widely Used Device

Presenter: Stephen G. Ellis, Takeshi Kimura, Hiram G. Bezerra

October 31, 2017

Advertisement

TCT 69: Optimal P2Y12 inhibitor strategy after acute coronary syndrome: a network meta-analysis of randomised controlled trials

TCT 772: Optimal Antithrombotic Therapy in Patients with Peripheral Artery Disease: A Systematic Review and Network Meta-analysis of Randomized Clinical Trials

Revascularization vs. Optimal Medical Therapy of Chronic Total Occlusions for Symptom Relief and Quality of Life: From the EUROCTO and DECISION-CTO Randomized Trials

Defining an Optimal Result of Transcatheter Tricuspid Valve Intervention: Results From the Tri-QOL Study

TRISCEND II Trial: Transcatheter Valve Replacement vs. Optimal Medical Therapy for Severe Tricuspid Regurgitation

TCT 390: Characteristics Associated With Optimal Stent Expansion in Patients With Calcified Lesions Receiving Rotational Atherectomy With or Without Cutting Balloon: A Secondary Analysis From the ROTA-CUT Randomized Trial

TCT 362: Optimal Pre-Dilatation Treatment Before Implantation of a Magmaris Bioresorbable Scaffold in Coronary Artery Stenosis: The OPTIMIS Trial

TCT 515: Optimal Antiplatelet Strategy for Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. A trial-sequential, bivariate, influential, and network meta-analysis

TCT 417: Ten-Year Clinical Outcomes After Randomization to PCI of a Concurrent Chronic Total Coronary Occlusion or Optimal Medical Therapy Alone in Patients With STEMI: Extended Follow-Up of the EXPLORE Trial

TCT 670: Sub-optimal OCT-guiding and Association with Two-year Clinical Outcomes - An OCTOBER Trial Substudy

Ten-Year Clinical Outcomes after PCI of a Concurrent Chronic Total Coronary Occlusion or Optimal Medical Therapy Alone in Patients with STEMI: Extended Follow-Up of the EXPLORE trial

TCT 304: Non-Invasive Assessment of Microvascular Dysfunction After Optimal Coronary Artery Stent Deployment; Insight From Acetyl Salicylic Elimination Trial (ASET) Japan

TCT 199: A Symptom-Stratified Analysis of the Objective Randomised Blinded Investigation With Optimal Medical Therapy of Angioplasty in Stable Angina Trial

Endovascular Sequestration of High-Risk Carotid Lesions Using the MicroNET-Covered Embolic Prevention Stent in Consecutive Patients With Symptoms or Signs of Carotid Stenosis-Related Cerebral Injury: An Investigator-Initiated, Intravascular, Ultrasound…

Heart Failure Interventions – Defining Optimal Medical Therapy in a Device Trial, From FDA Perspective

Heart Failure Interventions – Defining Optimal Medical Therapy in a Device Trial, From Academic Perspective

COMPASS Trial Revisited: Weighing Rivaroxaban Secondary Prevention vs DAPT After PCI

TCT-1: Optimal Duration of Dual Antiplatelet Therapy After Left Main Coronary Stenting With Everolimus-Eluting Stents: Analysis From the EXCEL Trial

OPTIMA Trial: P2Y12 Dose Adjustment for East-Asian ACS Patients

Debate: With Improved Technology and Optimal Technique ABSORB Will Become a Widely Used Device

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content